ArticleMethods in molecular biology (Clifton, N.J.)2026
Emerging Manufacturing Technologies in Freeze-Drying of Pharmaceuticals.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Freeze-drying of pharmaceutical products is an energy-intensive operation in pharmaceutical manufacturing. Emerging process-intensification and continuous-manufacturing technologies are now reshaping this traditionally static process. Among these, microwave-assisted freeze-drying, suspended-vial freeze-drying, and spin freeze-drying have demonstrated substantial reductions in cycle time, i.e., up to 80%-90%, while maintaining product stability and uniformity. These approaches enhance heat and mass transfer by replacing conduction through fixed shelves with volumetric or radiative energy delivery and thin-film geometries. Integrated Process Analytical Technology tools, coupled with mechanistic models and digital twins, enable real-time monitoring, predictive control, and potentially real-time release testing. The suspended-vial and spin freeze-drying platforms further enable continuous operation through modular design and automated vial transfer, aligning with the broader transition toward Pharmaceutical Manufacturing 4.0. Although regulatory adoption requires demonstrating sterility assurance, data integrity, and robust PAT validation, these technologies offer a credible path toward faster, safer, and more sustainable lyophilization.
Indexed as
Identifiers
42732495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.